{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T05:14:07Z","timestamp":1787030047648,"version":"build-2736575974"},"reference-count":135,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2022,12,14]],"date-time":"2022-12-14T00:00:00Z","timestamp":1670976000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Guangdong Provincial Forestry Department\u2019s Provincial Financial Special Fund for Ecological Forestry Construction and Wildlife Conservation","award":["31972707"],"award-info":[{"award-number":["31972707"]}]},{"name":"Guangdong Provincial Forestry Department\u2019s Provincial Financial Special Fund for Ecological Forestry Construction and Wildlife Conservation","award":["2021B1212050021"],"award-info":[{"award-number":["2021B1212050021"]}]},{"name":"Guangdong Provincial Forestry Department\u2019s Provincial Financial Special Fund for Ecological Forestry Construction and Wildlife Conservation","award":["2019A1515011534"],"award-info":[{"award-number":["2019A1515011534"]}]},{"name":"Guangdong Provincial Animal Disease Field Scientific Observation and Research Station Project","award":["31972707"],"award-info":[{"award-number":["31972707"]}]},{"name":"Guangdong Provincial Animal Disease Field Scientific Observation and Research Station Project","award":["2021B1212050021"],"award-info":[{"award-number":["2021B1212050021"]}]},{"name":"Guangdong Provincial Animal Disease Field Scientific Observation and Research Station Project","award":["2019A1515011534"],"award-info":[{"award-number":["2019A1515011534"]}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["31972707"],"award-info":[{"award-number":["31972707"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2021B1212050021"],"award-info":[{"award-number":["2021B1212050021"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2019A1515011534"],"award-info":[{"award-number":["2019A1515011534"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccines"],"abstract":"<jats:p>Since the SARS-CoV-2 outbreak, pharmaceutical companies and researchers worldwide have worked hard to develop vaccines and drugs to end the SARS-CoV-2 pandemic. The potential pathogen responsible for Coronavirus Disease 2019 (COVID-19), SARS-CoV-2, belongs to a novel lineage of beta coronaviruses in the subgenus arbovirus. Antiviral drugs, convalescent plasma, monoclonal antibodies, and vaccines are effective treatments for SARS-CoV-2 and are beneficial in preventing infection. Numerous studies have already been conducted using the genome sequence of SARS-CoV-2 in comparison with that of other SARS-like viruses, and numerous treatments\/prevention measures are currently undergoing or have already undergone clinical trials. We summarize these studies in depth in the hopes of highlighting some key details that will help us to better understand the viral origin, epidemiology, and treatments of the virus.<\/jats:p>","DOI":"10.3390\/vaccines10122145","type":"journal-article","created":{"date-parts":[[2022,12,15]],"date-time":"2022-12-15T02:20:57Z","timestamp":1671070857000},"page":"2145","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["SARS-CoV-2: An Updated Review Highlighting Its Evolution and Treatments"],"prefix":"10.3390","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8096-6440","authenticated-orcid":false,"given":"Xirui","family":"Zhang","sequence":"first","affiliation":[{"name":"Guangdong Provincial Key Laboratory of Zoonosis Prevention and Control, College of Veterinary Medicine, South China Agricultural University, Guangzhou 510642, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Yuan","sequence":"additional","affiliation":[{"name":"Guangdong Provincial Key Laboratory of Zoonosis Prevention and Control, College of Veterinary Medicine, South China Agricultural University, Guangzhou 510642, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zipeng","family":"Yang","sequence":"additional","affiliation":[{"name":"Guangdong Provincial Key Laboratory of Zoonosis Prevention and Control, College of Veterinary Medicine, South China Agricultural University, Guangzhou 510642, China"},{"name":"Institute of Animal Health, Guangdong Academy of Agricultural Sciences, Key Laboratory of Livestock Disease Prevention of Guangdong Province, Scientific Observation and Experiment Station of Veterinary Drugs and Diagnostic Techniques of Guangdong Province, Ministry of Agriculture and Rural Affairs, Guangzhou 510640, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Hu","sequence":"additional","affiliation":[{"name":"Guangdong Provincial Key Laboratory of Zoonosis Prevention and Control, College of Veterinary Medicine, South China Agricultural University, Guangzhou 510642, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1975-3454","authenticated-orcid":false,"given":"Yasser S.","family":"Mahmmod","sequence":"additional","affiliation":[{"name":"Infectious Diseases, Department of Animal Medicine, Faculty of Veterinary Medicine, Zagazig University, Zagazig 44511, Egypt"},{"name":"Veterinary Sciences Division, Al Ain Men\u2019s College, Higher Colleges of Technology, Abu Dhabi 17155, United Arab Emirates"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojing","family":"Zhu","sequence":"additional","affiliation":[{"name":"Guangdong Provincial Key Laboratory of Zoonosis Prevention and Control, College of Veterinary Medicine, South China Agricultural University, Guangzhou 510642, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cuiping","family":"Zhao","sequence":"additional","affiliation":[{"name":"The 80th Army Hospital of the Chinese people\u2019s Liberation Army, Weifang 261021, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8891-279X","authenticated-orcid":false,"given":"Jingbo","family":"Zhai","sequence":"additional","affiliation":[{"name":"Key Laboratory of Zoonose Prevention and Control at Universities of Inner Mongolia Autonomous Region, Medical College, Inner Mongolia Minzu University, Tongliao 028000, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiu-Xiang","family":"Zhang","sequence":"additional","affiliation":[{"name":"Guangdong Provincial Key Laboratory of Zoonosis Prevention and Control, College of Veterinary Medicine, South China Agricultural University, Guangzhou 510642, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengjun","family":"Luo","sequence":"additional","affiliation":[{"name":"Institute of Animal Health, Guangdong Academy of Agricultural Sciences, Key Laboratory of Livestock Disease Prevention of Guangdong Province, Scientific Observation and Experiment Station of Veterinary Drugs and Diagnostic Techniques of Guangdong Province, Ministry of Agriculture and Rural Affairs, Guangzhou 510640, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Hu","family":"Wang","sequence":"additional","affiliation":[{"name":"Institute of Animal Health, Guangdong Academy of Agricultural Sciences, Key Laboratory of Livestock Disease Prevention of Guangdong Province, Scientific Observation and Experiment Station of Veterinary Drugs and Diagnostic Techniques of Guangdong Province, Ministry of Agriculture and Rural Affairs, Guangzhou 510640, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4427-7285","authenticated-orcid":false,"given":"Mengzhou","family":"Xue","sequence":"additional","affiliation":[{"name":"Department of Cerebrovascular Diseases, The Second Affiliated Hospital of Zhengzhou University, Zhengzhou 450014, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8797-1322","authenticated-orcid":false,"given":"Chunfu","family":"Zheng","sequence":"additional","affiliation":[{"name":"Institute of Animal Health, Guangdong Academy of Agricultural Sciences, Key Laboratory of Livestock Disease Prevention of Guangdong Province, Scientific Observation and Experiment Station of Veterinary Drugs and Diagnostic Techniques of Guangdong Province, Ministry of Agriculture and Rural Affairs, Guangzhou 510640, China"},{"name":"Department of Microbiology, Immunology and Infectious Diseases, University of Calgary, Calgary, AB T2N 4N1, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3592-4743","authenticated-orcid":false,"given":"Zi-Guo","family":"Yuan","sequence":"additional","affiliation":[{"name":"Guangdong Provincial Key Laboratory of Zoonosis Prevention and Control, College of Veterinary Medicine, South China Agricultural University, Guangzhou 510642, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,12,14]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.jhep.2020.09.031","article-title":"COVID-19: Discovery, diagnostics and drug development","volume":"74","author":"Asselah","year":"2021","journal-title":"J. Hepatol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s10460-020-10066-0","article-title":"COVID-19-does social distancing include species distancing?","volume":"37","author":"Giseke","year":"2020","journal-title":"Agric. Hum. Values"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/j.chom.2022.06.010","article-title":"Emergence and widespread circulation of a recombinant SARS\u2013CoV\u20132 lineage in North America","volume":"30","author":"Gutierrez","year":"2022","journal-title":"Cell Host Microbe"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"e0029622","DOI":"10.1128\/jvi.00296-22","article-title":"A Capsidless Virus Is trans\u2014Encapsidated by a Bisegmented Botybirnavirus","volume":"96","author":"Jia","year":"2022","journal-title":"J. Virol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"671263","DOI":"10.3389\/fmolb.2021.671263","article-title":"Current Strategies of Antiviral Drug Discovery for COVID-19","volume":"8","author":"Mei","year":"2021","journal-title":"Front. Mol. Biosci."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.matpr.2021.07.163","article-title":"SARS\u2013CoV 2 spike protein S1 subunit as an ideal target for stable vaccines: A. bioinformatic study","volume":"49","author":"Nagesha","year":"2022","journal-title":"Mater. Today Proc."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"607886","DOI":"10.3389\/fmolb.2021.607886","article-title":"SARS\u2013CoV\u20132 Spike Protein Extrapolation for COVID Diagnosis and Vaccine Development","volume":"8","author":"Malik","year":"2021","journal-title":"Front. Mol. Biosci."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"101688","DOI":"10.1016\/j.tmaid.2020.101688","article-title":"Presumptive asymptomatic COVID-19 carriers\u2019 estimation and expected person\u2013to\u2013person spreading among repatriated passengers returning from China","volume":"37","author":"Camero","year":"2020","journal-title":"Travel. Med. Infect. Dis."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1056\/NEJMoa2001316","article-title":"Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus\u2013Infected Pneumonia","volume":"382","author":"Li","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2000058","DOI":"10.2807\/1560-7917.ES.2020.25.4.2000058","article-title":"Pattern of early human\u2013to\u2013human transmission of Wuhan 2019 novel coronavirus (2019\u2013nCoV), December 2019 to January 2020","volume":"25","author":"Riou","year":"2020","journal-title":"Euro. Surveill."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1056\/NEJMc2001468","article-title":"Transmission of 2019\u2013nCoV Infection from an Asymptomatic Contact in Germany","volume":"382","author":"Rothe","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s12985-016-0479-5","article-title":"Coronaviruses and the human airway: A universal system for virus\u2013host interaction studies","volume":"13","author":"Jonsdottir","year":"2016","journal-title":"Virol. J."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2000045","DOI":"10.2807\/1560-7917.ES.2020.25.3.2000045","article-title":"Detection of 2019 novel coronavirus (2019\u2013nCoV) by real\u2013time RT\u2013PCR","volume":"25","author":"Corman","year":"2020","journal-title":"Euro. Surveill."},{"key":"ref_14","first-page":"1056","article-title":"A Novel Coronavirus from Patients with Pneumonia in China, 2019","volume":"10","author":"Zhu","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_15","first-page":"438","article-title":"Viral and Bacterial Etiology of Acute Febrile Respiratory Syndrome among Patients in Qinghai, China","volume":"32","author":"Liu","year":"2019","journal-title":"Biomed. Environ. Sci."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1038\/s41591-021-01377-8","article-title":"Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS\u2013CoV\u20132 infection","volume":"27","author":"Khoury","year":"2021","journal-title":"Nat. Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","article-title":"A pneumonia outbreak associated with a new coronavirus of probable bat origin","volume":"579","author":"Zhou","year":"2020","journal-title":"Nature"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/s41586-020-2169-0","article-title":"Identifying SARS\u2013CoV\u20132 related coronaviruses in Malayan pangolins","volume":"583","author":"Lam","year":"2020","journal-title":"Nature"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0140-6736(20)30251-8","article-title":"Genomic characterisation and epidemiology of 2019 novel coronavirus: Implications for virus origins and receptor binding","volume":"395","author":"Lu","year":"2020","journal-title":"Lancet"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41586-020-2008-3","article-title":"A new coronavirus associated with human respiratory disease in China","volume":"579","author":"Wu","year":"2020","journal-title":"Nature"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/S0140-6736(21)00370-6","article-title":"SARS-CoV-2 variants and ending the COVID-19 pandemic","volume":"397","author":"Fontanet","year":"2021","journal-title":"Lancet"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/s41426-018-0155-5","article-title":"Genomic characterization and infectivity of a novel SARS\u2013like coronavirus in Chinese bats","volume":"7","author":"Hu","year":"2018","journal-title":"Emerg. Microbes Infect."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/S0140-6736(20)30154-9","article-title":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person\u2013to\u2013person transmission: A study of a family cluster","volume":"395","author":"Chan","year":"2020","journal-title":"Lancet"},{"key":"ref_24","first-page":"e18981","article-title":"Evolutionary Perspective and Theories on the Possible Origin of SARS-CoV-2","volume":"13","author":"Saeed","year":"2021","journal-title":"Cureus"},{"key":"ref_25","first-page":"1002","article-title":"The 2019\u2013new coronavirus epidemic: Evidence for virus evolution","volume":"10","author":"Benvenuto","year":"2020","journal-title":"J. Med. Virol."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Yadav, R., Chaudhary, J.K., Jain, N., Chaudhary, P.K., Khanra, S., Dhamija, P., and Sharma, A. (2021). Role of Structural and Non\u2013Structural Proteins and Therapeutic Targets of SARS\u2013CoV\u20132 for COVID-19. Cells, 10.","DOI":"10.3390\/cells10040821"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1001\/jama.2020.12603","article-title":"Persistent Symptoms in Patients After Acute COVID-19","volume":"324","author":"Bernabei","year":"2020","journal-title":"JAMA"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1056\/NEJMcp2009575","article-title":"Severe Covid\u201319","volume":"383","author":"Berlin","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s13024-021-00469-w","article-title":"Post\u2013infection cognitive impairments in a cohort of elderly patients with COVID-19","volume":"16","author":"Liu","year":"2021","journal-title":"Mol. Neurodegener."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"De Vito, A., Fiore, V., Princic, E., Geremia, N., Panu Napodano, C.M., Muredda, A.A., Maida, I., Madeddu, G., and Babudieri, S. (2021). Predictors of infection, symptoms development, and mortality in people with SARS\u2013CoV\u20132 living in retirement nursing homes. PLoS ONE, 16.","DOI":"10.1371\/journal.pone.0248009"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1126\/science.ade1675","article-title":"COVID-19 and children","volume":"377","author":"Pierce","year":"2022","journal-title":"Science"},{"key":"ref_32","first-page":"1489","article-title":"New Insights on COVID-19\u2019s Hyperinflammation in Children","volume":"324","author":"Kuehn","year":"2020","journal-title":"JAMA"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/S2213-2600(20)30152-1","article-title":"COVID-19 infection in children","volume":"8","author":"Sinha","year":"2020","journal-title":"Lancet Respir. Med."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1080\/09546634.2020.1791309","article-title":"A probable atypical skin manifestation of COVID-19 infection","volume":"33","author":"Shahidi","year":"2022","journal-title":"J. Dermatol. Treat."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1016\/j.cmi.2020.05.017","article-title":"Anosmia in COVID-19 patients","volume":"26","author":"Hornuss","year":"2020","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S2213-2600(20)30076-X","article-title":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome","volume":"8","author":"Xu","year":"2020","journal-title":"Lancet Respir. Med."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.annonc.2020.03.296","article-title":"Clinical characteristics of COVID-19\u2013infected cancer patients: A retrospective case study in three hospitals within Wuhan, China","volume":"31","author":"Zhang","year":"2020","journal-title":"Ann. Oncol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"827","DOI":"10.3389\/fimmu.2020.00827","article-title":"Reduction and Functional Exhaustion of T Cells in Patients with Coronavirus Disease 2019 (COVID-19)","volume":"11","author":"Diao","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.kint.2020.03.005","article-title":"Kidney impairment is associated with in\u2013hospital death of COVID-19 patients","volume":"97","author":"Cheng","year":"2020","journal-title":"Kidney Int."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/nature17180","article-title":"Therapeutic efficacy of the small molecule GS\u20135734 against Ebola virus in rhesus monkeys","volume":"531","author":"Warren","year":"2016","journal-title":"Nature"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"eabc8482","DOI":"10.1126\/sciadv.abc8482","article-title":"Macrophage activation on \u201cphagocytic synapse\u201d arrays: Spacing of nanoclustered ligands directs TLR1\/2 signaling with an intrinsic limit","volume":"6","author":"Li","year":"2020","journal-title":"Sci. Adv."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1056\/NEJMoa2001191","article-title":"First Case of 2019 Novel Coronavirus in the United States","volume":"382","author":"Holshue","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/s13020-020-00393-z","article-title":"Anti\u2013COVID-19 drug screening: Frontier concepts and core technologies","volume":"15","author":"Luo","year":"2020","journal-title":"Chin. Med."},{"key":"ref_44","first-page":"104","article-title":"A preliminary study on the reproductive toxicity of GS\u20135734 on male mice","volume":"5","author":"Fan","year":"2020","journal-title":"BioRxiv"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"e00162","DOI":"10.1128\/CMR.00162-20","article-title":"Remdesivir against COVID-19 and Other Viral Diseases","volume":"34","author":"Malin","year":"2020","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1056\/NEJMoa2015301","article-title":"Remdesivir for 5 or 10 Days in Patients with Severe COVID-19","volume":"383","author":"Goldman","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/S0140-6736(20)31022-9","article-title":"Remdesivir in adults with severe COVID-19: A randomised, double\u2013blind, placebo\u2013controlled, multicentre trial","volume":"395","author":"Wang","year":"2020","journal-title":"Lancet"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1056\/NEJMoa2007764","article-title":"Remdesivir for the Treatment of Covid\u201319\u2013Final Report","volume":"383","author":"Beigel","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1056\/NEJMoa2116846","article-title":"Early Remdesivir to Prevent Progression to Severe Covid\u201319 in Outpatients","volume":"386","author":"Gottlieb","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1080\/03007995.2022.2129801","article-title":"Reduced risk of death in people with SARS\u2013CoV\u20132 infection treated with remdesivir: A nested case\u2013control study","volume":"38","author":"Poliseno","year":"2022","journal-title":"Curr. Med. Res. Opin."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1097\/CM9.0000000000002104","article-title":"A trial of arbidol hydrochloride in adults with COVID-19","volume":"135","author":"Zhao","year":"2022","journal-title":"Chin. Med. J."},{"key":"ref_52","first-page":"91","article-title":"Favipiravir","volume":"68","author":"Vora","year":"2020","journal-title":"J. Assoc. Physicians India"},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Golan, Y., Campos, J.A.S., and Woolson, R. (2022). Favipiravir in patients with early mild\u2013to\u2013moderate COVID-19: A randomized controlled trial. Clin. Infect. Dis., Preprint.","DOI":"10.1093\/cid\/ciac712"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.3389\/fphar.2020.01071","article-title":"No Statistically Apparent Difference in Antiviral Effectiveness Observed Among Ribavirin Plus Interferon\u2013Alpha, Lopinavir\/Ritonavir Plus Interferon\u2013Alpha, and Ribavirin Plus Lopinavir\/Ritonavir Plus Interferon\u2013Alpha in Patients With Mild to Moderate Coronavirus Disease 2019: Results of a Randomized, Open\u2013Labeled Prospective Study","volume":"11","author":"Huang","year":"2020","journal-title":"Front. Pharmacol."},{"key":"ref_55","first-page":"64","article-title":"Baricitinib bei COVID-19\u2013Patienten","volume":"163","author":"Facharztmagazine","year":"2021","journal-title":"MMW Fortschr. Med."},{"key":"ref_56","first-page":"202","article-title":"An EUA for baricitinib (Olumiant) for COVID-19","volume":"62","author":"Drugs","year":"2020","journal-title":"Med. Lett. Drugs Ther."},{"key":"ref_57","first-page":"275","article-title":"Can Tofacitinib Offer Protection against COVID-19 Infection?","volume":"395","author":"Goldberger","year":"2021","journal-title":"Ski. Appendage Disord."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1056\/NEJMoa2101643","article-title":"Tofacitinib in Patients Hospitalized with Covid\u201319 Pneumonia","volume":"385","author":"Quirk","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"60","DOI":"10.18773\/austprescr.2022.014","article-title":"Molnupiravir for COVID-19","volume":"45","author":"Prescriber","year":"2022","journal-title":"Aust. Prescr."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ejim.2022.05.024","article-title":"Efficacy and safety of molnupiravir for COVID-19 patients","volume":"102","author":"Fatima","year":"2022","journal-title":"Eur. J. Intern. Med."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Najjar-Debbiny, R., Gronich, N., Weber, G., Khoury, J., Amar, M., Stein, N., Goldstein, L.H., and Saliba, W. (2022). Effectiveness of Molnupiravir in High Risk Patients: A Propensity Score Matched Analysis. Clin. Infect. Dis., ciac781. (Online ahead of print).","DOI":"10.1093\/cid\/ciac781"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"5582","DOI":"10.1002\/jmv.28011","article-title":"Safety and efficacy of molnupiravir in SARS-CoV-2-infected patients: A real-life experience","volume":"94","author":"Colpani","year":"2022","journal-title":"J. Med. Virol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"e523","DOI":"10.1016\/S2665-9913(20)30235-6","article-title":"Effect of anakinra in COVID-19","volume":"2","author":"Kooistra","year":"2020","journal-title":"Lancet Rheumatol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1016\/S1473-3099(22)00507-2","article-title":"Real\u2013world effectiveness of early molnupiravir or nirmatrelvir\u2013ritonavir in hospitalised patients with COVID-19 without supplemental oxygen requirement on admission during Hong Kong\u2019s omicron BA.2 wave: A retrospective cohort study","volume":"22","author":"Wong","year":"2022","journal-title":"Lancet Infect. Dis."},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Gentile, I., Scotto, R., Schiano Moriello, N., Pinchera, B., Villari, R., Trucillo, E., Ametrano, L., Fusco, L., Castaldo, G., and Buonomo, A.R. (2022). Nirmatrelvir\/Ritonavir and Molnupiravir in the Treatment of Mild\/Moderate COVID-19: Results of a Real\u2013Life Study. Vaccines, 10.","DOI":"10.1101\/2022.08.23.22278585"},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Focosi, D., and Casadevall, A. (2022). A Critical Analysis of the Use of Cilgavimab plus Tixagevimab Monoclonal Antibody Cocktail (Evusheld\u2122) for COVID-19 Prophylaxis and Treatment. Viruses, 14.","DOI":"10.3390\/v14091999"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.ccell.2022.05.007","article-title":"Activity of AZD7442 (tixagevimab\u2013cilgavimab) against Omicron SARS\u2013CoV\u20132 in patients with hematologic malignancies","volume":"40","author":"Stuver","year":"2022","journal-title":"Cancer Cell"},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Karaba, A.H., Kim, J., Chiang, T.P.-Y., Alejo, J.L., Abedon, A.T., Mitchell, J., Chang, A., Eby, Y., Johnston, T.S., and Aytenfisu, T.Y.J.m. (2022). Omicron BA. 1 and BA. 2 Neutralizing Activity Following Pre\u2013Exposure Prophylaxis with Tixagevimab plus Cilgavimab in Vaccinated Solid Organ Transplant Recipients. MedRxiv, Preprint.","DOI":"10.1101\/2022.05.24.22275467"},{"key":"ref_69","first-page":"3130","article-title":"Tixagevimab\/cilgavimab pre\u2013exposure prophylaxis is associated with lower breakthrough infection risk in vaccinated solid organ transplant recipients during the omicron wave","volume":"2","author":"Morena","year":"2022","journal-title":"Am. J. Transplant."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"196","DOI":"10.5582\/ddt.2022.01055","article-title":"Listing of the neutralizing antibodies amubarvimab and romlusevimab in China: Hopes and impediments","volume":"16","author":"Liu","year":"2022","journal-title":"Drug Discov. Ther."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1126\/scitranslmed.abf1906","article-title":"The neutralizing antibody, LY\u2013CoV555, protects against SARS\u2013CoV\u20132 infection in nonhuman primates","volume":"13","author":"Jones","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1056\/NEJMoa2102685","article-title":"Bamlanivimab plus Etesevimab in Mild or Moderate Covid\u201319","volume":"385","author":"Dougan","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1001\/jama.2021.0202","article-title":"Effect of Bamlanivimab as Monotherapy or in Combination with Etesevimab on Viral Load in Patients with Mild to Moderate COVID-19: A Randomized Clinical Trial","volume":"325","author":"Gottlieb","year":"2021","journal-title":"JAMA"},{"key":"ref_74","first-page":"49","article-title":"An EUA for bamlanivimab and etesevimab for COVID-19","volume":"63","author":"Drugs","year":"2021","journal-title":"Med. Lett. Drugs Ther."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1056\/NEJMoa2035002","article-title":"REGN\u2013COV2, a Neutralizing Antibody Cocktail, in Outpatients with COVID-19","volume":"384","author":"Weinreich","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1001\/jama.2022.2832","article-title":"Effect of Sotrovimab on Hospitalization or Death Among High\u2013risk Patients With Mild to Moderate COVID-19: A Randomized Clinical Trial","volume":"327","author":"Gupta","year":"2022","journal-title":"JAMA"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1056\/NEJMoa2030340","article-title":"Tocilizumab in Patients Hospitalized with Covid\u201319 Pneumonia","volume":"384","author":"Salama","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"ofac517","DOI":"10.1093\/ofid\/ofac517","article-title":"Evaluation of Bebtelovimab for Treatment of Covid\u201319 During the SARS\u2013CoV\u20132 Omicron Variant Era","volume":"9","author":"McCreary","year":"2022","journal-title":"Open. Forum. Infect. Dis."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"e463","DOI":"10.1097\/TP.0000000000004278","article-title":"Bebtelovimab for Treatment of COVID-19 in Ambulatory Solid Organ Transplant Recipients","volume":"106","author":"Shertel","year":"2022","journal-title":"Transplantation"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"624","DOI":"10.3389\/fmed.2021.624924","article-title":"Mortality Benefit of Convalescent Plasma in COVID-19: A Systematic Review and Meta\u2013Analysis","volume":"8","author":"Bansal","year":"2021","journal-title":"Front. Med."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1001\/jama.2021.2747","article-title":"Association of Convalescent Plasma Treatment with Clinical Outcomes in Patients with COVID-19: A Systematic Review and Meta\u2013analysis","volume":"325","author":"Janiaud","year":"2021","journal-title":"JAMA"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s12288-021-01417-w","article-title":"Efficacy and Safety of Convalescent Plasma for COVID-19: A Systematic Review and Meta\u2013analysis","volume":"37","author":"Prasad","year":"2021","journal-title":"Indian J. Hematol. Blood Transfus."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1056\/NEJMoa2103784","article-title":"Early Convalescent Plasma for High\u2013Risk Outpatients with COVID-19","volume":"385","author":"Korley","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S1473-3099(06)70361-9","article-title":"New insights into the antiviral effects of chloroquine","volume":"6","author":"Savarino","year":"2006","journal-title":"Lancet Infect. Dis."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/cr.2012.165","article-title":"Anti\u2013malaria drug chloroquine is highly effective in treating avian influenza A H5N1 virus infection in an animal model","volume":"23","author":"Yan","year":"2013","journal-title":"Cell Res."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/1743-422X-2-69","article-title":"Chloroquine is a potent inhibitor of SARS coronavirus infection and spread","volume":"2","author":"Vincent","year":"2005","journal-title":"Virol. J."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"e20200413","DOI":"10.36416\/1806-3756\/e20200413","article-title":"New CT finding (the target sign) in three patients with COVID-19 pneumonia","volume":"46","author":"Martins","year":"2020","journal-title":"J. Bras. Pneumol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/d41586-020-01165-3","article-title":"Chloroquine hype is derailing the search for coronavirus treatments","volume":"580","author":"Ledford","year":"2020","journal-title":"Nature"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.autrev.2018.08.002","article-title":"Immunogenicity, safety and tolerability of anti\u2013pneumococcal vaccination in systemic lupus erythematosus patients: An evidence\u2013informed and PRISMA compliant systematic review and meta\u2013analysis","volume":"18","author":"Adawi","year":"2019","journal-title":"Autoimmun. Rev."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"106212","DOI":"10.1016\/j.ijantimicag.2020.106212","article-title":"Frequency of Long QT in Patients with SARS\u2013CoV\u20132 Infection Treated with Hydroxychloroquine: A Meta\u2013analysis","volume":"56","author":"Oscanoa","year":"2020","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"7132","DOI":"10.1038\/s41598-021-86679-0","article-title":"Ivermectin reduces in vivo coronavirus infection in a mouse experimental model","volume":"11","author":"Pagotto","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"186","DOI":"10.2144\/btn-2020-0142","article-title":"High\u2013purity DNA extraction from animal tissue using picking in the TRIzol\u2013based method","volume":"70","author":"Bo","year":"2020","journal-title":"Biotechniques"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/j.1472-8206.2009.00684.x","article-title":"Avermectin exerts anti\u2013inflammatory effect by downregulating the nuclear transcription factor kappa\u2013B and mitogen\u2013activated protein kinase activation pathway","volume":"23","author":"Ci","year":"2009","journal-title":"Fundam. Clin. Pharmacol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"e001350","DOI":"10.1136\/openhrt-2020-001350","article-title":"Ivermectin may be a clinically useful anti\u2013inflammatory agent for late\u2013stage COVID-19","volume":"7","author":"DiNicolantonio","year":"2020","journal-title":"Open Heart"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"3023","DOI":"10.21873\/invivo.12134","article-title":"Ivermectin Docks to the SARS\u2013CoV\u20132 Spike Receptor\u2013binding Domain Attached to ACE2","volume":"34","author":"Lehrer","year":"2020","journal-title":"Vivo"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"102779","DOI":"10.1016\/j.amsu.2021.102779","article-title":"Effectiveness and Safety of Niclosamaide as Add\u2013on Therapy to the Standard of Care Measures in COVID-19 Management: Randomized controlled clinical trial","volume":"69","author":"Abdulamir","year":"2021","journal-title":"Ann. Med. Surg."},{"key":"ref_97","doi-asserted-by":"crossref","unstructured":"Okumu\u015f, N., Demirt\u00fcrk, N., Cetinkaya, R.A., G\u00fcner, R., Avc\u0131, \u0130.Y., Orhan, S., Konya, P., \u015eaylan, B., Karalezli, A., and Yamanel, L. (2021). Evaluation of the effectiveness and safety of adding ivermectin to treatment in severe COVID-19 patients. BMC Infect. Dis., 21.","DOI":"10.1186\/s12879-021-06104-9"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"343","DOI":"10.18433\/jpps32105","article-title":"Evaluation of Ivermectin as a Potential Treatment for Mild to Moderate COVID-19: A Double\u2013Blind Randomized Placebo Controlled Trial in Eastern India","volume":"24","author":"Ravikirti","year":"2021","journal-title":"J. Pharm. Pharm. Sci."},{"key":"ref_99","doi-asserted-by":"crossref","unstructured":"Jurgeit, A., McDowell, R., Moese, S., Meldrum, E., Schwendener, R., and Greber, U.F. (2012). Niclosamide Is a Proton Carrier and Targets Acidic Endosomes with Broad Antiviral Effects. PLOS Pathog., 8.","DOI":"10.1371\/journal.ppat.1002976"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"109765","DOI":"10.1016\/j.mehy.2020.109765","article-title":"Plausible mechanisms of Niclosamide as an antiviral agent against COVID-19","volume":"140","author":"Pindiprolu","year":"2020","journal-title":"Med. Hypotheses"},{"key":"ref_101","first-page":"454","article-title":"Analysis of prescription and medication rules of traditional Chinese medicine in the treatment of the coronavirus disease 2019 based on traditional Chinese medicine inheritance support platform","volume":"34","author":"Liu","year":"2022","journal-title":"Zhonghua Wei Zhong Bing Ji Jiu Yi Xue"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s13643-020-01343-4","article-title":"Traditional Chinese herbal medicine for treating novel coronavirus (COVID-19) pneumonia: Protocol for a systematic review and meta\u2013analysis","volume":"9","author":"Li","year":"2020","journal-title":"Syst. Rev."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"7020","DOI":"10.18632\/aging.202557","article-title":"The efficiency and safety of high\u2013dose vitamin C in patients with COVID-19: A retrospective cohort study","volume":"13","author":"Gao","year":"2021","journal-title":"Aging"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"e25876","DOI":"10.1097\/MD.0000000000025876","article-title":"High\u2013dose vitamin C intravenous infusion in the treatment of patients with COVID-19: A protocol for systematic review and meta\u2013analysis","volume":"100","author":"Huang","year":"2021","journal-title":"Medicine"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"102189","DOI":"10.1016\/j.dsx.2021.102189","article-title":"Vitamin D supplementation and COVID-19 treatment: A systematic review and meta\u2013analysis","volume":"15","author":"Rawat","year":"2021","journal-title":"Diabetes. Metab. Syndr."},{"key":"ref_106","first-page":"802","article-title":"Should we supplement zinc in COVID-19 patients? Evidence from a meta\u2013analysis","volume":"131","author":"Szarpak","year":"2021","journal-title":"Pol. Arch. Intern. Med."},{"key":"ref_107","first-page":"8","article-title":"COVID-19 vaccines buoy hope","volume":"20","author":"Mullard","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1056\/NEJMp2005630","article-title":"Developing Covid\u201319 Vaccines at Pandemic Speed","volume":"382","author":"Lurie","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_109","doi-asserted-by":"crossref","unstructured":"Agus, D.B., Nguyen, A., and Sall, A.A. (2022). COVID-19 and other adult vaccines can drive global disease prevention. Lancet, Preprint.","DOI":"10.1016\/S0140-6736(22)02084-0"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/s41577-022-00749-6","article-title":"Vaccines only partially protect against Long COVID","volume":"22","author":"Immunology","year":"2022","journal-title":"Nat. Rev. Immunol."},{"key":"ref_111","first-page":"435","article-title":"COVID-19 vaccines start moving into advanced trials","volume":"19","author":"Mullard","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"751598","DOI":"10.3389\/fmed.2021.751598","article-title":"Potential Triggers for Thrombocytopenia and\/or Hemorrhage by the BNT162b2 Vaccine, Pfizer\u2013BioNTech","volume":"8","author":"Okada","year":"2021","journal-title":"Front. Med."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1097\/TP.0000000000004059","article-title":"Real\u2013world Effectiveness of the Pfizer\u2013BioNTech BNT162b2 and Oxford\u2013AstraZeneca ChAdOx1\u2013S Vaccines Against SARS\u2013CoV\u20132 in Solid Organ and Islet Transplant Recipients","volume":"106","author":"Callaghan","year":"2022","journal-title":"Transplantation"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"105253","DOI":"10.1016\/j.antiviral.2022.105253","article-title":"The omicron (B.1.1.529) SARS\u2013CoV\u20132 variant of concern does not readily infect Syrian hamsters","volume":"198","author":"Abdelnabi","year":"2022","journal-title":"Antivir. Res."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1056\/NEJMoa2107058","article-title":"Prevention and Attenuation of COVID-19 with the BNT162b2 and mRNA\u20131273 Vaccines","volume":"385","author":"Thompson","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1001\/jamainternmed.2021.4325","article-title":"Association of BNT162b2 mRNA and mRNA\u20131273 Vaccines With COVID-19 Infection and Hospitalization among Patients with Cirrhosis","volume":"181","author":"John","year":"2021","journal-title":"JAMA Intern. Med."},{"key":"ref_117","first-page":"S2213","article-title":"Safety of the fourth COVID-19 BNT162b2 mRNA (second booster) vaccine: A prospective and retrospective cohort study","volume":"18","author":"Yechezkel","year":"2022","journal-title":"Lancet Respir. Med."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1056\/NEJMc2206900","article-title":"Omicron SARS\u2013CoV\u20132 Neutralization from Inactivated and ZF2001 Vaccines","volume":"387","author":"Zhao","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1056\/NEJMc2119912","article-title":"SARS\u2013CoV\u20132 Omicron Variant Neutralization after mRNA\u20131273 Booster Vaccination","volume":"386","author":"Pajon","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1056\/NEJMc2115597","article-title":"Phase 3 Trial of mRNA\u20131273 during the Delta\u2013Variant Surge","volume":"385","author":"Baden","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.jfma.2022.02.020","article-title":"Immune response and safety of heterologous ChAdOx1\u2013nCoV\u201319\/mRNA\u20131273 vaccination compared with homologous ChAdOx1\u2013nCoV\u201319 or homologous mRNA\u20131273 vaccination","volume":"121","author":"Sheng","year":"2022","journal-title":"J. Formos. Med. Assoc."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"e85","DOI":"10.1056\/NEJMoa2114228","article-title":"Waning Immunity after the BNT162b2 Vaccine in Israel","volume":"385","author":"Goldberg","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1056\/NEJMoa2102214","article-title":"Efficacy of the ChAdOx1 nCoV\u201319 COVID-19 Vaccine against the B.1.351 Variant","volume":"384","author":"Madhi","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1056\/NEJMoa2104882","article-title":"Thrombosis and Thrombocytopenia after ChAdOx1 nCoV\u201319 Vaccination","volume":"384","author":"Schultz","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1056\/NEJMoa2105385","article-title":"Pathologic Antibodies to Platelet Factor 4 after ChAdOx1 nCoV\u201319 Vaccination","volume":"384","author":"Scully","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1056\/NEJMc2103916","article-title":"Antibody Persistence through 6 Months after the Second Dose of mRNA\u20131273 Vaccine for COVID-19","volume":"384","author":"Suthar","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJMoa2035389","article-title":"Efficacy and Safety of the mRNA\u20131273 SARS\u2013CoV\u20132 Vaccine","volume":"384","author":"Baden","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"e147553","DOI":"10.1172\/JCI147553","article-title":"COVID-19 vaccine testing in pregnant females is necessary","volume":"131","author":"Klein","year":"2021","journal-title":"J. Clin. Investig."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/S2213-2600(21)00366-0","article-title":"Heterologous ChAdOx1\u2013nCoV19\u2013BNT162b2 vaccination provides superior immunogenicity against COVID-19","volume":"9","author":"Richardson","year":"2021","journal-title":"Lancet Respir. Med."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1056\/NEJMp2009457","article-title":"Drug Evaluation during the COVID-19 Pandemic","volume":"382","author":"Rome","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.ijid.2020.01.009","article-title":"The continuing 2019\u2013nCoV epidemic threat of novel coronaviruses to global health\u2013The latest 2019 novel coronavirus outbreak in Wuhan, China","volume":"91","author":"Hui","year":"2020","journal-title":"Int. J. Infect. Dis."},{"key":"ref_132","doi-asserted-by":"crossref","unstructured":"Wong, A.C.P., Li, X., Lau, S.K.P., and Woo, P.C.Y. (2019). Global Epidemiology of Bat Coronaviruses. Viruses, 11.","DOI":"10.3390\/v11020174"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","article-title":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study","volume":"395","author":"Chen","year":"2020","journal-title":"Lancet"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0140-6736(20)30300-7","article-title":"What to do next to control the 2019\u2013nCoV epidemic?","volume":"395","author":"Wang","year":"2020","journal-title":"Lancet"}],"container-title":["Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-393X\/10\/12\/2145\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:41:12Z","timestamp":1760146872000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-393X\/10\/12\/2145"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,14]]},"references-count":135,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["vaccines10122145"],"URL":"https:\/\/doi.org\/10.3390\/vaccines10122145","relation":{},"ISSN":["2076-393X"],"issn-type":[{"value":"2076-393X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,14]]}}}